Evidence map›Paper›PMID 22011440›Full record

ArticleMolecular pain2011

PAP and NT5E inhibit nociceptive neurotransmission by rapidly hydrolyzing nucleotides to adenosine.

Sarah E Street, Paul L Walsh, Nathaniel A Sowa, Bonnie Taylor-Blake, Thomas S Guillot, Pirkko Vihko, R Mark Wightman, Mark J Zylka

Open access · goldAbstract read
In one paragraph

Article in Molecular pain, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Purinergic Signaling in Endometriosis-Associated Pain.International journal of molecular sciences · 2020
    Review
  8. Article
  9. Electrochemistry at the Synapse.Annual review of analytical chemistry (Palo Alto, Calif.) · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Caffeine inhibits hypothalamic ANature communications · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Sarah E StreetDepartment of Cell and Molecular Physiology, University of North Carolina, CB #7545, Chapel Hill, North Carolina 27599, USA.
Paul L Walsh
Nathaniel A Sowa
Bonnie Taylor-Blake
Thomas S Guillot
Pirkko Vihko
R Mark Wightman
Mark J Zylka
University of North Carolina at Chapel Hill · USUniversity of Helsinki · FI

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008719 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DARVILLE, TONI, DESHMUKH, MOHANISH P · 1999 to 2023
$15.1M
Harnessing ectonucleotidases to treat chronic painR01NS067688 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZYLKA, MARK J. · 2009 to 2013
$3.6M
SECRETION FROM INDIVIDUAL VESICLESR01NS038879 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WIGHTMAN, ROBERT MARK · 1999 to 2012
$3.1M
Biochemical Modulation of Nociceptive CircuitsR01NS060725 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZYLKA, MARK J. · 2007 to 2010
$1.3M
Mechanism of prostatic acid phosphatase-mediated analgesiaF30NS063507 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SOWA, NATHANIEL A · 2008 to 2011
$114k
NIGMS NIH HHS T32GM008719NINDS NIH HHS F30NS063507NINDS NIH HHS R01NS038879NINDS NIH HHS R01NS060725NINDS NIH HHS R01 NS067688NINDS NIH HHS R01NS067688
6 · The paper itself

Abstract

backgroundProstatic acid phosphatase (PAP) and ecto-5'-nucleotidase (NT5E, CD73) produce extracellular adenosine from the nucleotide AMP in spinal nociceptive (pain-sensing) circuits; however, it is currently unknown if these are the main ectonucleotidases that generate adenosine or how rapidly they generate adenosine.

resultsWe found that AMP hydrolysis, when measured histochemically, was nearly abolished in dorsal root ganglia (DRG) neurons and lamina II of spinal cord from Pap/Nt5e double knockout (dKO) mice. Likewise, the antinociceptive effects of AMP, when combined with nucleoside transport inhibitors (dipyridamole or 5-iodotubericidin), were reduced by 80-100% in dKO mice. In addition, we used fast scan cyclic voltammetry (FSCV) to measure adenosine production at subsecond resolution within lamina II. Adenosine was maximally produced within seconds from AMP in wild-type (WT) mice but production was reduced >50% in dKO mice, indicating PAP and NT5E rapidly generate adenosine in lamina II. Unexpectedly, we also detected spontaneous low frequency adenosine transients in lamina II with FSCV. Adenosine transients were of short duration (<2 s) and were reduced (>60%) in frequency in Pap-/-, Nt5e-/- and dKO mice, suggesting these ectonucleotidases rapidly hydrolyze endogenously released nucleotides to adenosine. Field potential recordings in lamina II and behavioral studies indicate that adenosine made by these enzymes acts through the adenosine A1 receptor to inhibit excitatory neurotransmission and nociception.

conclusionsCollectively, our experiments indicate that PAP and NT5E are the main ectonucleotidases that generate adenosine in nociceptive circuits and indicate these enzymes transform pulsatile or sustained nucleotide release into an inhibitory adenosinergic signal.

Indexed as

5'-NucleotidaseAcid PhosphataseAdenosineAdenosine MonophosphateAnimalsDipyridamoleGanglia, SpinalMaleMiceMice, KnockoutNociceptionNucleotidesPainProtein Tyrosine PhosphatasesReceptor, Adenosine A1Synaptic Transmission5-iodotubercidin5'-NucleotidaseAcid PhosphataseAdenosineAdenosine MonophosphateDipyridamoleNucleotidesprostatic acid phosphataseProtein Tyrosine PhosphatasesReceptor, Adenosine A1Tubercidin

Identifiers

PMID22011440
PMCPMC3210096
OpenAlexW2111106575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.